Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11024017 | 0.82 | KEAP1 (0.44) | ALDH1A1KDM4EKEAP1NFE2L2KMT2A | |
| SCHEMBL28740904 | 0.82 | ALDH1A1 (0.48) | ALDH1A1KDM4EKEAP1NFE2L2KMT2A | |
| SCHEMBL28240608 | 0.79 | KEAP1 (0.42) | ALDH1A1KDM4EKEAP1NFE2L2KMT2A | |
| SCHEMBL5412466 | 0.79 | ALDH1A1 (0.47) | ALDH1A1KDM4EKMT2AHTTL3MBTL1 | |
| SCHEMBL1204858 | 0.78 | ALDH1A1 (0.54) | ALDH1A1KDM4EKMT2AHTTL3MBTL1 | |
| SCHEMBL10180137 | 0.78 | ALDH1A1 (0.46) | ALDH1A1KDM4EKMT2AHTTL3MBTL1 | |
| SCHEMBL1204933 | 0.78 | ALDH1A1 (0.46) | ALDH1A1KDM4EKMT2AHTTL3MBTL1 | |
| SCHEMBL385916 | 0.78 | KEAP1 (0.46) | ALDH1A1KDM4EKEAP1NFE2L2KMT2A | |
| SCHEMBL7194392 | 0.77 | KEAP1 (0.57) | ALDH1A1KDM4EKEAP1NFE2L2KMT2A | |
| SCHEMBL3882288 | 0.77 | PSIP1 (0.50) | ALDH1A1KDM4EKEAP1NFE2L2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104379560-A | Benzamide derivative | CHUGAI PHARMACEUTICAL CO LTD | 2015-02-25 | — | — | CN | disclosed |
| CN-104379568-A | Quinazolinedione derivative | CHUGAI PHARMACEUTICAL CO LTD | 2015-02-25 | — | — | CN | disclosed |
| US-8124810-B2 | Preparation of isoxazolin-3-ylacylbenzenes | BASF SE (DE) | 2012-02-28 | — | — | US | disclosed |
| US-8049017-B2 | Preparation of isoxazolin-3-ylacylbenzenes | BASF SE (DE) | 2011-11-01 | — | — | US | disclosed |
| US-20110152535-A1 | PREPARATION OF ISOXAZOLIN-3-YLACYLBENZENES | RHEINHEIMER JOACHIM | 2011-06-23 | — | — | US | disclosed |
| CN-101113137-B | Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation | BASF AG | 2010-12-29 | — | — | CN | disclosed |
| US-20100105920-A1 | PREPARATION OF ISOXAZOLIN-3-YLACYLBENZENES | BASF SE (DE) | 2010-04-29 | — | — | US | disclosed |
| US-7663001-B2 | Preparation of isoxazolin-3-ylacylbenzene | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-16 | — | — | US | disclosed |
| CN-100516030-C | Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation | BASF AG (DE) | 2009-07-22 | — | — | CN | disclosed |
| CN-101113137-A | Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation | BASF AG (DE) | 2008-01-30 | — | — | CN | disclosed |
| CN-1300284-A | Preparation of isoxazolin-3-yl-acylbenzenes | BASF AG (DE) | 2001-06-20 | — | — | CN | disclosed |
| US-6040367-A | EXCELLENT RESISTANCE TO AN IONIZING RADIATION, IN WHICH HETEROCYCLIC COMPOUND CONTAINING OXYMETHYLENE UNITS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5977206-A | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-11-02 | — | — | US | disclosed |
| US-5948838-A | 0.01 TO 5 PARTS BY WEIGHT OF A COMPOUND CONTAINING OXYMETHYLENE UNIT | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0794218-A2 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-09-10 | — | — | EP | disclosed |
| EP-0753540-A2 | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-01-15 | — | — | EP | disclosed |
| EP-0380578-B1 | A PROCESS FOR THE PREPARATION OF 1,4-DISUBSTITUTED 2-BUTENES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5189199-A | Process for the preparation of 1,4-disubstituted 2-butenes | EASTMAN KODAK COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0380578-A1 | A PROCESS FOR THE PREPARATION OF 1,4-DISUBSTITUTED 2-BUTENES. | EASTMAN KODAK CO (US) | 1990-08-08 | — | — | EP | disclosed |
| WO-1989002883-A1 | A PROCESS FOR THE PREPARATION OF 1,4-DISUBSTITUTED 2-BUTENES | EASTMAN KODAK COMPANY (US) | 1989-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152535-A1 | PREPARATION OF ISOXAZOLIN-3-YLACYLBENZENES | CBR3, CYP4X1, UQCRB | ALDH1A1 549/4885KDM4E 2534/4885KEAP1 2189/4885 |
| US-20100105920-A1 | PREPARATION OF ISOXAZOLIN-3-YLACYLBENZENES | CBR3, CYP4X1, UQCRB | ALDH1A1 549/4885KDM4E 2534/4885KEAP1 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.